MAIA Biotechnology EPS MAIA

Diluted earnings per share by quarter and over the last twelve months, from 2021.

MAIA Biotechnology's earnings per share was −$0.64 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.13.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$0.13	n/a	−$0.64
Q1 FY26	Mar 31, 2026	−$0.14	n/a	−$0.69
Q4 FY25	Dec 31, 2025	−$0.10	n/a	−$0.71
Q3 FY25	Sep 30, 2025	−$0.27	n/a	−$0.75
Q2 FY25	Jun 30, 2025	−$0.18	n/a	−$0.59
Q1 FY25	Mar 31, 2025	−$0.16	n/a	−$0.81
Q4 FY24	Dec 31, 2024	−$0.14	n/a	−$1.11
Q3 FY24	Sep 30, 2024	−$0.11	n/a	−$1.37
Q2 FY24	Jun 30, 2024	−$0.40	n/a	−$1.62
Q1 FY24	Mar 31, 2024	−$0.46	n/a	−$1.57
Q4 FY23	Dec 31, 2023	−$0.40	n/a	−$1.49
Q3 FY23	Sep 30, 2023	−$0.36	n/a	−$1.47

Companies in Drug Manufacturers - General nearest MAIA Biotechnology's size, closest first, today.

Company	EPS, 12 months	Growth
MAIAMAIA Biotechnology	−$0.64
LFVNLifevantage	$0.40	−46% a year
SPROSpero Therapeutics	$0.11
ATNMActinium Pharmaceuticals	$0.36
NATRNatures Sunshine Products	$1.01	+36% a year
ARVNArvinas	$0.16
PBYIPuma Biotechnology	$0.52	−47% a year
IRWDIronwood Pharmaceuticals	$0.77
ZVRAZevra Therapeutics	$0.93
CRMDCorMedix	$2.13	+184% a year
Peer median	$0.52